News

High Concentration mAb Formulations and Their Properties Monoclonal antibodies (mAbs) are the predominant class of recombinant biologic drugs in development, having first emerged as therapeutics in the 1980s. While intravenous (IV) infusion is a commonly-used administration route for mAbs, subcutaneous delivery (sub-C)...

Possessing the world’s strongest cargo flight network and building the trade bridges between continents, Turkish Cargo also contributes greatly to Turkey’s exports. For over the last 60 years, Flag carrier air cargo brand has been carrying the rose products...

The Vietnamese pharmaceutical company Vabiotech confirmed on Wednesday the production of the first test batch of the Russian Sputnik V coronavirus vaccine at its facilities. Prior to that, the Russian Direct Investment Fund (RDIF) announced the start of production...

Genezen Laboratories Inc. a cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has further strengthened its senior leadership team with the appointment of Brok Weichbrodt as Vice President of Operations. Previously the Director of Commercial Operations at Catalent,...

Lonza and CN Bio have entered into a distribution agreement whereby Lonza will supply a selection of hepatic cells to be prequalified by CN Bio for use in their PhysioMimix™ Single-and Multi-Organ MPS to transform the way human-relevant pre-clinical...

ArisGlobal, the leading provider of life sciences software that automates core drug development functions for over 300 life sciences companies, announced that Shanghai Xihua Scientific Co. Ltd., a fast-growing provider of late-phase drug research and development services for the...

Twist Bioscience Corporation , a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and MOLCURE Inc., announced they generated potent, binding antibodies to an undisclosed oncology target for Twist’s internal pipeline...